Internal Medicine, Gastroenterology · Summerfield, FL
NPI
1609089853
Since 2007
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
17345 SE 109th Terrace Rd
Summerfield, FL, 34491
Phone (352) 751-4885
Groups this clinician bills Medicare through
Medicare paid, 2024
$292K
2,132 services
Medicare patients, 2024
1,064
Average age 75
Drug cost, 2024
$830K
1,774 prescriptions
Company payments, 2025
$12K
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mariana de Jongh-Beyer was code 99213 (office e&m - established), 482 times for 344 patients. In total Mariana de Jongh-Beyer billed 2,132 services in 30 codes, and Medicare paid $292K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 482 | 344 | $68.78 | $33K |
| 45385 Colonoscopy - Lesion Removal | Facility | 277 | 277 | $224.88 | $62K |
| 43239 Upper GI Endoscopy | Facility | 272 | 263 | $70.91 | $19K |
| 46221 Digestive/Gastrointestinal | Office | 223 | 63 | $224.66 | $50K |
| 45380 Lower GI Endoscopy - Other | Facility | 199 | 198 | $128.07 | $25K |
| 99204 Office E&M - New | Office | 121 | 121 | $120.73 | $15K |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 112 | 112 | $194.12 | $22K |
| 43248 Upper GI Endoscopy | Facility | 93 | 90 | $133.93 | $12K |
| 99203 Office E&M - New | Office | 77 | 77 | $72.97 | $5,619 |
| 99214 Office E&M - Established | Office | 69 | 63 | $99.31 | $6,853 |
| 64561 Neurostimulator - Back | Facility | 49 | 49 | $383.74 | $19K |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 29 | 29 | $195.17 | $5,660 |
| 45378 Lower GI Endoscopy - Other | Facility | 28 | 28 | $157.02 | $4,397 |
| 45331 Lower GI Endoscopy - Other | Facility | 26 | 26 | $57.65 | $1,499 |
| 99223 Hospital E&M - Initial | Facility | 16 | 16 | $146.15 | $2,338 |
By year: 2022 $219K for 1,536 services; 2023 $249K for 1,837 services; 2024 $292K for 2,132 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mariana de Jongh-Beyer prescribed most often to Medicare patients was Sod Sulf-Potass Sulf-Mag Sulf (Sodium, Potassium,mag Sulfates), with 611 prescriptions and refills. In total Mariana de Jongh-Beyer wrote 1,774 Medicare prescriptions that cost $830K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 611 | 611 | 608 | $36K |
| Pantoprazole Sodium Generic | 365 | 814 | 146 | $5,000 |
| Famotidine Generic | 144 | 339 | 57 | $2,095 |
| Omeprazole Generic | 103 | 264 | 44 | $2,056 |
| Sucralfate Generic | 59 | 109 | 25 | $4,493 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 55 | 67 | 18 | $2,033 |
| Linzess Linaclotide | 55 | 81 | 14 | $43K |
| Dicyclomine Hcl Generic | 36 | 54 | 14 | $613 |
| Colestipol Hcl Generic | 27 | 58 | 11 | $2,483 |
| Humira(Cf) Pen Adalimumab | 26 | 26 | Under 11 | $184K |
| Ondansetron Odt Ondansetron | 24 | 25 | 15 | $767 |
| Mesalamine Generic | 23 | 40 | Under 11 | $5,098 |
| Esomeprazole Magnesium Generic | 16 | 39 | Under 11 | $735 |
| Budesonide Dr Budesonide | 15 | 39 | 11 | $2,596 |
| Creon Lipase/Protease/Amylase | 14 | 24 | Under 11 | $81K |
Brand drugs: 438 claims; generic drugs: 1,336 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mariana de Jongh-Beyer $12K ($12K in general payments such as food, travel and fees) from 1 company. The largest payer was Medtronic, Inc. with $12K.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 7 | $12K |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.